Entries by aaron

Impaired Fasting Glucose and Sulfonylureas Raise Heart Risk in Inflammatory Arthritis

Researchers have discovered in a new study that impaired fasting glucose (IFG) and sulfonylurea use are independently linked with an enhanced risk of major cardiovascular events (MACE) in inflammatory arthritis (IA) patients, including rheumatoid arthritis (RA) and psoriatic arthritis (PsA). The findings of the study underscore vigilance in screening fasting glucose level and adjusting choices […]

Implantable Device Shows Long-Term Benefits for Urinary Incontinence, Reveals Research

USA: An implantable tibial neuromodulation system, known as Revi, significantly improved quality of life and symptoms in women with urgency urinary incontinence (UUI) over 24 months, according to research presented at the American Urological Association Annual Meeting and published in The Journal of Urology. The researchers note that the participants who did not meet the […]

Inflammation May Be the Link Between Chronic Pain and Depression, suggests study

Chronic pain-or pain that lasts at least three months-is closely intertwined with depression. Individuals living with pain’s persistent symptoms may be up to four times more likely to experience depression, research shows. Almost 30% of people worldwide suffer from a chronic pain condition such as low back pain and migraines, and one in three of […]

Obstructive Sleep Apnea Found to Increase Risk of Sick Sinus Syndrome, unravels study

A recent study revealed that individuals with an inherited susceptibility to obstructive sleep apnea (OSA) are at increased risk for developing sick sinus syndrome (SSS), a bradyarrhythmia involving the heart’s own pacemaker. The study was conducted by Chen W. and fellow researchers published in the journal Nature and Science of Sleep. OSA is a prevalent […]

Previous Gastrectomy independent risk factor for POBL Risk in laparoscopic liver resection Patients: Study

Researchers have found in a new research that previous gastrectomy was as an independent risk factor for post-operative bile leakage (POBL) in patients undergoing laparoscopic liver resection (LLR). Further in order to reduce the incidence of POBL in high-risk cases, meticulous surgical techniques and comprehensive perioperative management are essential. Postoperative bile leakage is a common […]

Thrombectomy Patients Face Higher Stroke Risk After 90 Days, Study Finds

USA: A recent real-world data analysis has highlighted concerns about the long-term outcomes of acute ischemic stroke patients treated with mechanical thrombectomy. While the procedure remains a vital intervention in the acute phase, the study found that risks persist well beyond the initial 90-day recovery period. “Patients who underwent thrombectomy faced a 25% higher risk […]

Guideline on platelet and plasma transfusion released by American College of Chest Physicians

The American College of Chest Physicians® (CHEST) recently released a new clinical guideline on the transfusion of fresh frozen plasma (FFP) andplatelets in critically ill adults. Published in the journal CHEST®, the guideline contains seven evidence-based recommendations to provide a framework for clinicians to implement in their own facilities. “In practice, we see all too […]

Pregnancy and Calcium: Study suggests how to Tackle Silent Issue of Hypocalcemia during pregnancy

Maternal hypocalcemia is a significant healthcare issue characterized by low serum calcium levels during pregnancy. This condition is largely influenced by the physiological demands of pregnancy and inadequate dietary calcium intake, particularly prevalent in African nations with socio-economic challenges. The global prevalence of hypocalcemia among pregnant women ranges from 25.5% to 70.6%, with higher instances […]

FDA Approves Zevaskyn for Treating RDEB-Related Blistering Wounds

The U.S. Food and Drug Administration (FDA) has approved prademagene zamikeracel (Zevaskyn) for the treatment of blistering wounds caused by recessive dystrophic epidermolysis bullosa (RDEB) in both adults and children, according to an announcement by Abeona Therapeutics. There is no cure for RDEB and ZEVASKYN is the only FDA-approved product to treat RDEB wounds with […]